வலேரி தாக்கேட்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வலேரி தாக்கேட்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வலேரி தாக்கேட்ட் Today - Breaking & Trending Today

Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer's and related diseases

Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases
January 14, 2021 at 3:54 pm
Valerie Daggett, founder and CEO of AltPep. (UW Photo)
AltPep, a Seattle-based biotech startup tackling amyloid protein disorders, has raised $23.1 million in a Series A funding round.
The venture spun out the University of Washington in March 2019. Its founder and CEO is Valerie Daggett, a longtime professor in the Department of Bioengineering in the College of Engineering.
AltPep is developing tools and treatments for diseases caused by amyloid proteins that are incorrectly folded and create harmful deposits. These deposits can lead to numerous amyloid diseases including Alzheimer’s, Parkinson’s, type-2 diabetes, some kinds of drug-resistant bacterial infections, and dozens more. ....

College Of Engineering , Al Qahirah , Al Iskandariyah , Athira Pharma , Joel Marcus , David Goel , Valerie Daggett , Seattle Northlake , Patrik Edenholm , Kurt Becker , Chuck Horne , Todd Patrick , University Of Washington , Armata Pharmaceuticals , Lake Union , Motion Labs , Chad Robins , Adaptive Biotechnologies , Matrix Capital Management , Alexandria Real Estate , Alexandria Venture , கல்லூரி ஆஃப் பொறியியல் , அதிரா பார்மா , ஜோயல் மார்கஸ் , டேவிட் கோயல் , வலேரி தாக்கேட்ட் ,

AltPep Raises $23M Jumpstarting Work on Alzheimer's Disease

AltPep Raises $23M Jumpstarting Work on Alzheimer s Disease
Search jobs
SEATTLE - January 14, 2021 - (Newswire.com)
AltPep Corporation, a privately held biomedical company focused on diagnosing and treating Central Nervous System amyloid disorders, starting with Alzheimer s Disease, today announced it closed a $23.150 million Series A investment round. Matrix Capital Management led the investment, with significant participation by Alexandria Venture Investments. In conjunction with the financing, David Goel, Managing General Partner and Founder of Matrix Capital Management and Joel Marcus, Executive Chairman and Founder of Alexandria Real Estate Equities/Alexandria Venture Investments, have joined the AltPep Board of Directors.
The proceeds of the Series A investment will be used to advance a breakthrough technology developed at the University of Washington laboratory of AltPep Founder and CEO, Valerie Daggett, Ph.D., that targets the misfolded ....

United States , University Of Washington , Al Iskandariyah , North Lake , David Goel , Valerie Daggett , Patrik Edenholm , Joel Marcus , Todd Patrick , Altpep Corporation , Armata Pharmaceuticals , Alexandria Real Estate Equities , Pep Corporation , Central Nervous System , Capital Management , Alexandria Venture , Managing General Partner , Matrix Capital Management , Executive Chairman , Alexandria Real Estate , Alexandria Venture Investments , Altpep Board , Altpep Founder , Managing Partner , Matrix Capital , Chad Robins ,

Investigating abnormal protein structures in Alzheimer's and other diseases

Investigating abnormal protein structures in Alzheimer's and other diseases
dailyuw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyuw.com Daily Mail and Mail on Sunday newspapers.

Valerie Daggett , Dylan Shea , Elaine Peskind , National Institute On , Uw School Of Medicine , National Institute , வலேரி தாக்கேட்ட் , டிலான் ஷியா , எலைன் பேஸ்கிண்ட் , தேசிய நிறுவனம் ஆன் , ஊவ் பள்ளி ஆஃப் மருந்து , தேசிய நிறுவனம் ,